Questions for summit: 1)what is Dr Andersons current role and contribution to the cause, silence from him or about him it seems? 2) IF we are 90% close to matching our biggest competitor (says phil b) who offers an invasive product, I would think time lines and expectations (fda) and excitment would be forth coming very very soon? 3) Finances ... after the reverse split, our advantage was we didn't have a lot of shares outstanding, low float etc, BUT LET'S NOT REPEAT WHAT LED US TO THE REVERSE SPLIT ALL OVER AGAIN! 4) how can we leverage all of our intellectual property? From all the past years, not one marketable product ever came through, whether sumitomo, IV, IBD, DIAMONDS, MILK, VODKA, etcetc. But is all of that dead? We still have all theses patents tho so how to we make big $ on those ... 5) what about huge strategic well known partner - apple? Every one it would seem would want a piece of the Holy grail of non invasive glucose monitoring
News 
Market Data 
Discover 
